IL1β Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-κB

Stem Cell Reviews and Reports

Volumn 8, Issue 3, 2012, Pages 905-916

  Carrero, Rubén ^a   Cerrada, Inmaculada ^a,b   Lledó, Elisa ^b   Dopazo, Joaquín ^c,d   García García, Francisco ^c,d   Rubio, Mari Paz ^d   Trigueros, César ^e   Dorronsoro, Akaitz ^e   Ruiz Sauri, Amparo ^f   Montero, José Anastasio ^a   Sepúlveda, Pilar ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^c National Institute for Bioinformatics   (Spain)

^d CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^e Fundacion Inbiomed   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chemotaxis; Interleukin 1 ; Mesenchymal stem cells; Migration and adhesion

Indexed keywords

AUTACOID; CHEMOKINE; COLLAGEN; FIBRONECTIN; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LAMININ; SIGNAL PEPTIDE;

ARTICLE; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CELL STRAIN HEK293; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; HUMAN; LEUKOCYTE; MESENCHYMAL STROMA CELL; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; COLLAGEN; FIBRONECTINS; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; LAMININ; LEUKOCYTES; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84865564723     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9364-9     Document Type: Article

References (44)

1. Pereira, R. F., O'Hara, M. D., Laptev, A. V., Halford, K. W., Pollard, M. D., Class, R., Simon, D., Livezey, K., & Prockop, D. J. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proceedings of the National Academy of Sciences of the United States of America, 95, 1142-7.
2. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S., Ide, C., & Nabeshima, Y. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309, 314-7.
3. McFarlin, K., Gao, X., Liu, Y. B., Dulchavsky, D. S., Kwon, D., Arbab, A. S., Bansal, M., Li, Y., Chopp, M., Dulchavsky, S. A., & Gautam, S. C. (2006). Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair and Regeneration, 14, 471-8.
4. Chen, L., Tredget, E. E., Wu, P. Y., & Wu, Y. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 3, e1886.
5. Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., & Dzau, V. J. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal, 20, 661-9.
6. Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678-85.
7. Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research, 98, 1414-21.
8. Arminan, A., Gandia, C., Garcia-Verdugo, J. M., Lledo, E., Trigueros, C., Ruiz-Sauri, A., Minana, M. D., Solves, P., Paya, R., Montero, J. A., & Sepulveda, P. (2010). Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. Journal of the American College of Cardiology, 55, 2244-53.
9. Kawada, H., Fujita, J., Kinjo, K., Matsuzaki, Y., Tsuma, M., Miyatake, H., Muguruma, Y., Tsuboi, K., Itabashi, Y., Ikeda, Y., Ogawa, S., Okano, H., Hotta, T., Ando, K., & Fukuda, K. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood, 104, 3581-7.
10. Ponte, A. L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., Charbord, P., & Domenech, J. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells, 25, 1737-45.
11. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2, 141-50.
12. Greco, S. J., & Rameshwar, P. (2007). Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. Journal of Immunology, 179, 3342-50.
13. Bednarski, B. K., Ding, X., Coombe, K., Baldwin, A. S., & Kim, H. J. (2008). Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin. Molecular Cancer Therapeutics, 7, 1827-35.
14. Bolstad, B. M., Irizarry, R. A., Astrand, M., & Speed, T. P. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-93.
15. Al-Shahrour, F., Minguez, P., Tarraga, J., Medina, I., Alloza, E., Montaner, D., & Dopazo, J. (2007). FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Research, 35, W91-6.
16. Medina, I., Carbonell, J., Pulido, L., Madeira, S. C., Goetz, S., Conesa, A., Tarraga, J., Pascual-Montano, A., Nogales-Cadenas, R., Santoyo, J., Garcia, F., Marba, M., Montaner, D., & Dopazo, J. (2010). Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-3. doi: 10. 1093/nar/gkq388.
17. Moser, B., & Loetscher, P. (2001). Lymphocyte traffic control by chemokines. Nature Immunology, 2, 123-8.
18. Spanaus, K. S., Nadal, D., Pfister, H. W., Seebach, J., Widmer, U., Frei, K., Gloor, S., & Fontana, A. (1997). C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. Journal of Immunology, 158, 1956-64.
19. Gordon, S., & Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity, 32, 593-604.
20. Kim, H. S., Shin, T. H., Yang, S. R., Seo, M. S., Kim, D. J., Kang, S. K., Park, J. H., & Kang, K. S. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One 5: e15369.
21. TomcHuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., & Scandurro, A. B. (2008). Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells, 26, 99-107.
22. Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993). Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. The Journal of Clinical Investigation, 92, 1866-74.
23. Kim, Y. S., Park, H. J., Hong, M. H., Kang, P. M., Morgan, J. P., Jeong, M. H., Cho, J. G., Park, J. C., & Ahn, Y. (2009). TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Frontiers in Bioscience, 14, 2845-56.
24. Zhang, D., Fan, G. C., Zhou, X., Zhao, T., Pasha, Z., Xu, M., Zhu, Y., Ashraf, M., & Wang, Y. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 44, 281-92.
25. Hayden, M. S., & Ghosh, S. (2004). Signaling to NF-kappaB. Genes & Development, 18, 2195-224.
26. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., & Rao, A. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science, 278, 860-6.
27. Baker, R. G., Hayden, M. S., & Ghosh, S. (2011). NF-kappaB, inflammation, and metabolic disease. Cell Metab, 13, 11-22.
28. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-22.
29. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-43.
30. Raffaghello, L., Bianchi, G., Bertolotto, M., Montecucco, F., Busca, A., Dallegri, F., Ottonello, L., & Pistoia, V. (2008). Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells, 26, 151-62.
31. Bujak, M., & Frangogiannis, N. G. (2009). The role of IL-1 in the pathogenesis of heart disease. Archivum Immunologiae et Therapiae Experimentalis, 57, 165-76.
32. Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 11, 98-107.
33. Shaftel, S. S., Griffin, W. S., & O'Banion, M. K. (2008). The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. Journal of Neuroinflammation, 5, 7.
34. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., Lira, S. A., Habenicht, A. J., & Randolph, G. J. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. The Journal of Clinical Investigation, 117, 185-94.
35. Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004). Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cellular and molecular immunology, 1, 95-104.
36. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W., & Hare, J. M. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474-9.
37. Davani, S., Marandin, A., Mersin, N., Royer, B., Kantelip, B., Herve, P., Etievent, J. P., & Kantelip, J. P. (2003). Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation, 108(Suppl 1), II253-8.
38. Leotlela, P. D., Wade, M. S., Duray, P. H., Rhode, M. J., Brown, H. F., Rosenthal, D. T., Dissanayake, S. K., Earley, R., Indig, F. E., Nickoloff, B. J., Taub, D. D., Kallioniemi, O. P., Meltzer, P., Morin, P. J., & Weeraratna, A. T. (2007). Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene, 26, 3846-56.
39. Fujita, H., Chalubinski, M., Rhyner, C., Indermitte, P., Meyer, N., Ferstl, R., Treis, A., Gomez, E., Akkaya, A., O'Mahony, L., Akdis, M., & Akdis, C. A. (2011). Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol, 127, 1612-21 e8.
40. Liotta, F., Angeli, R., Cosmi, L., Fili, L., Manuelli, C., Frosali, F., Mazzinghi, B., Maggi, L., Pasini, A., Lisi, V., Santarlasci, V., Consoloni, L., Angelotti, M. L., Romagnani, P., Parronchi, P., Krampera, M., Maggi, E., Romagnani, S., & Annunziato, F. (2008). Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells, 26, 279-89.
41. Romieu-Mourez, R., Francois, M., Boivin, M. N., Bouchentouf, M., Spaner, D. E., & Galipeau, J. (2009). Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. Journal of Immunology, 182, 7963-73.
42. Brandau, S., Jakob, M., Hemeda, H., Bruderek, K., Janeschik, S., Bootz, F., & Lang, S. (2010). Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol, 88, 1005-15.
43. Crespo-Diaz, R., Behfar, A., Butler, G. W., Padley, D. J., Sarr, M. G., Bartunek, J., Dietz, A. B., & Terzic, A. (2011). Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplantation, 20, 797-811.
44. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. The FASEB Journal, 9, 899-909.